Literature DB >> 16384868

The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential.

Kazutoshi Miyashita1, Hiroshi Itoh, Hiroshi Arai, Takayasu Suganami, Naoki Sawada, Yasutomo Fukunaga, Masakatsu Sone, Kenichi Yamahara, Takami Yurugi-Kobayashi, Kwijun Park, Naofumi Oyamada, Naoya Sawada, Daisuke Taura, Hirokazu Tsujimoto, Ting-Hsing Chao, Naohisa Tamura, Masashi Mukoyama, Kazuwa Nakao.   

Abstract

Adrenomedullin (AM) is a vasodilating hormone secreted mainly from vascular wall, and its expression is markedly enhanced after stroke. We have revealed that AM promotes not only vasodilation but also vascular regeneration. In this study, we focused on the roles of AM in the ischemic brain and examined its therapeutic potential. We developed novel AM-transgenic (AM-Tg) mice that overproduce AM in the liver and performed middle cerebral artery occlusion for 20 min (20m-MCAO) to examine the effects of AM on degenerative or regenerative processes in ischemic brain. The infarct area and gliosis after 20m-MCAO was reduced in AM-Tg mice in association with suppression of leukocyte infiltration, oxidative stress, and apoptosis in the ischemic core. In addition, vascular regeneration and subsequent neurogenesis were enhanced in AM-Tg mice, preceded by increase in mobilization of CD34(+) mononuclear cells, which can differentiate into endothelial cells. The vasculo-neuro-regenerative actions observed in AM-Tg mice in combination with neuroprotection resulted in improved recovery of motor function. Brain edema was also significantly reduced in AM-Tg mice via suppression of vascular permeability. In vitro, AM exerted direct antiapoptotic and neurogenic actions on neuronal cells. Exogenous administration of AM in mice after 20m-MCAO also reduced the infarct area, and promoted vascular regeneration and functional recovery. In summary, this study suggests the neuroprotective and vasculo-neuro-regenerative roles of AM and provides basis for a new strategy to rescue ischemic brain through its multiple hormonal actions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384868     DOI: 10.1210/en.2005-1038

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.

Authors:  Colleen Glyde Julian; Andrew W Subudhi; Megan J Wilson; Andrew C Dimmen; Travis Pecha; Robert C Roach
Journal:  J Appl Physiol (1985)       Date:  2011-06-02

2.  Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.

Authors:  Takakuni Maki; Yoko Takahashi; Nobukazu Miyamoto; Anna C Liang; Masafumi Ihara; Eng H Lo; Ken Arai
Journal:  Stem Cell Res       Date:  2015-05-09       Impact factor: 2.020

3.  Adrenomedullin prevents sex-dependent impairment of autoregulation during hypotension after piglet brain injury through inhibition of ERK MAPK upregulation.

Authors:  William M Armstead; J Willis Kiessling; Khalil Bdeir; W Andrew Kofke; Monica S Vavilala
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

4.  Impaired cerebral blood flow autoregulation during posttraumatic arterial hypotension after fluid percussion brain injury is prevented by phenylephrine in female but exacerbated in male piglets by extracellular signal-related kinase mitogen-activated protein kinase upregulation.

Authors:  William M Armstead; J Willis Kiessling; W Andrew Kofke; Monica S Vavilala
Journal:  Crit Care Med       Date:  2010-09       Impact factor: 7.598

Review 5.  Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

Authors:  Farzaneh A Sorond; Shawn Whitehead; Ken Arai; Douglas Arnold; S Thomas Carmichael; Charles De Carli; Marco Duering; Myriam Fornage; Rafael E Flores-Obando; Jonathan Graff-Radford; Edith Hamel; David C Hess; Massafumi Ihara; Majken K Jensen; Hugh S Markus; Axel Montagne; Gary Rosenberg; Andy Y Shih; Eric E Smith; Alex Thiel; Kai Hei Tse; Donna Wilcock; Frank Barone
Journal:  Geroscience       Date:  2019-12-06       Impact factor: 7.713

6.  Phenylephrine infusion prevents impairment of ATP- and calcium-sensitive potassium channel-mediated cerebrovasodilation after brain injury in female, but aggravates impairment in male, piglets through modulation of ERK MAPK upregulation.

Authors:  William M Armstead; J Willis Kiessling; John Riley; W Andrew Kofke; Monica S Vavilala
Journal:  J Neurotrauma       Date:  2011-01       Impact factor: 5.269

7.  Peripheral administration of human adrenomedullin and its binding protein attenuates stroke-induced apoptosis and brain injury in rats.

Authors:  Wayne W Chaung; Rongqian Wu; Youxin Ji; Zhimin Wang; Weifeng Dong; Cletus Cheyuo; Lei Qi; Xiaoling Qiang; Haichao Wang; Ping Wang
Journal:  Mol Med       Date:  2011-06-17       Impact factor: 6.354

8.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

9.  The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia.

Authors:  Naofumi Oyamada; Masakatsu Sone; Kazutoshi Miyashita; Kwijun Park; Daisuke Taura; Megumi Inuzuka; Takuhiro Sonoyama; Hirokazu Tsujimoto; Yasutomo Fukunaga; Naohisa Tamura; Hiroshi Itoh; Kazuwa Nakao
Journal:  Endocrinology       Date:  2008-04-24       Impact factor: 4.736

10.  The potential neuroprotection mechanism of GDNF in the 6-OHDA-induced cellular models of Parkinson's Disease.

Authors:  Feng Li; Meng Wang; Shuan Zhu; Li Li; Ye Xiong; Dian-Shuai Gao
Journal:  Cell Mol Neurobiol       Date:  2013-07-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.